University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Pelin Cinar, MD, MS

Pelin Cinar, MD, MS

Medical Director of Quality and Safety, UCSF Helen Diller Family Comprehensive Cancer Center; Clinical Asst. Professor, Dept. of Gastrointestinal Oncology, UCSF

Cancer Center Program Memberships

Cancer Control

Education

University of California at Irvine, B.A., 06/2000, Anthropology
University of California at Irvine, B.S., 06/2000, Biological Sciences: Specialization in Physiology
University of California at Irvine, M.S., 06/2002, Environmental Health Science & Policy: Specialization in Epidemiology
UC Irvine School of Medicine, M.D., 06/2007, Doctor of Medicine
UC Irvine School of Medicine, 06/2010, Resident Physician
UCSF Medical Center, 06/2013, Hematology and Oncology Fellow
UCSF Medical Center, 01/2014, Hematology and Oncology Chief Fellow
American Society of Clinical Oncology (ASCO), 10/2015, ASCO Quality


Professional Experience

  • 2016-present
    Clinical Assistant Professor in Medicine, Department of Medicine, UCSF Medical Center, Division of Oncology
  • 2016-present
    Director of Quality Improvement, UCSF Helen Diller Family Comprehensive Cancer Center
  • 2015-2016
    Associate Director for Quality and Curriculum, Medical Oncology Fellowship Program, Stanford University Medical Center
  • 2014-2016
    Clinical Assistant Professor in Medicine, Department of Medicine, Division of Oncology, Stanford University Medical Center
  • 2014-2016
    Assistant Medical Director for Cancer Care Quality, Stanford Cancer Institute
  • 2013-2014
    Clinical Instructor, Department of Medicine, Division of Hematology/Oncology, UCSF Medical Center
  • 2013-2014
    Clinical Instructor Department of Medicine Division of Hematology/Oncology, San Francisco VA Medical Center

Honors & Awards

  • 2014
    Educational Travel Award, Mount Zion Health Fund
  • 2013
    Appointed as the Chief Fellow, UC San Francisco Hematology/Oncology Fellowship Program
  • 2012
    Selected as a Participant, 2012 AACR / ASCO Workshop: Methods in Clinical Cancer Research
  • 2012
    Educational Travel Award, Mount Zion Health Fund
  • 2008
    The David K. Litke, MD Memorial Intern of the Year Award, UC Irvine Department of Internal Medicine Residency Program
  • 2007
    Department of Medicine Award, UC Irvine School of Medicine
  • 2006
    Inducted into Gold Humanism Honor Society, UC Irvine School of Medicine
  • 2006
    Associated Medical Student Government (AMSG) Community Service Award, UC Irvine School of Medicine
  • 2005
    Outstanding Student / Resident Research Poster Award, “Medical Student Run Community Service Promoting Smoking Prevention in Orange County, CA Middle Schools” Western Group on Educational Affairs
  • 2004
    Nominated for AMSG Community Service Award, UC Irvine School of Medicine
  • 2000
    Initiated as a member of School of Biological Sciences Scholastic Honor Society, University of
    California at Irvine
  • 2000
    Initiated in Lambda Alpha Kappa, National Collegiate Honor Society for Anthropology, University of California at Irvine
  • 1999
    Summer Fellowship Award, American Cancer Society, Orange County Region
  • 1999
    Excellence in Research Poster Award, University

Selected Publications

  1. Cinar P, Ko AH. Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017. Chin Clin Oncol. 2017 Jun; 6(3):29.
    View on PubMed
  2. Cinar P, Calkins SM, Venook AP, Kelley RK. A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma. Anticancer Res. 2014 Dec; 34(12):7357-60.
    View on PubMed
  3. Cinar P, Ko AH. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma. J Natl Compr Canc Netw. 2014 Feb; 12(2):167-72.
    View on PubMed
  4. Cinar P, Tempero MA. Monoclonal antibodies and other targeted therapies for pancreatic cancer. Cancer J. 2012 Nov-Dec; 18(6):653-64.
    View on PubMed
  5. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 01; 26(1):66-75.
    View on PubMed

Go to UCSF Profiles, powered by CTSI